Caprotec Adds $1.4M in Series B
Caprotec Bioanalytics GmbH, a Berlin-based biopharmaceutical company, has added $1.4 million in a second tranche of its Series B round, bringing the total raised in the round to $7.2 million. LBBW Venture Capital , Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds, and other undisclosed investors contributed to the round. Caprotec is based in Berlin, with operations in Burlington, Mass.
10 May 2011•2 mins read
